Patent · US Active

Pharmaceutical formulation containing irritant

US7727557B2 · kind B2 · utility

89Cited by
3References
24Claims
0Family size

Assignee

Inventor

Key dates

Filing dateSep 22, 2006
Grant dateJun 1, 2010
Priority date
Expiry dateFeb 22, 2027

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K9/5026
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed in certain embodiments is an oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse; and an effective amount of an irritant to impart an irritating sensation to an abuser upon administration of said dosage form after tampering.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.